Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
James A. Pearson, Andrew Agriantonis, F. Susan Wong & Li Wen. (2018) Modulation of the immune system by the gut microbiota in the development of type 1 diabetes. Human Vaccines & Immunotherapeutics 14:11, pages 2580-2596.
Read now
Read now
Stefano Bibbò, Maria Pina Dore, Giovanni Mario Pes, Giuseppe Delitala & Alessandro P. Delitala. (2017) Is there a role for gut microbiota in type 1 diabetes pathogenesis?. Annals of Medicine 49:1, pages 11-22.
Read now
Read now
Articles from other publishers (73)
Datis Kharrazian, Martha Herbert & Jama Lambert. (2023) The Relationships between Intestinal Permeability and Target Antibodies for a Spectrum of Autoimmune Diseases. International Journal of Molecular Sciences 24:22, pages 16352.
Crossref
Crossref
Radhika R. Gudi, Benjamin M. Johnson, Marie‐Claude Gaudreau, Wei Sun, Lauren Ball & Chenthamarakshan Vasu. (2023)
Intestinal permeability and inflammatory features of juvenile age correlate with the eventual systemic autoimmunity in lupus‐prone female
SWR × NZB F1
(
SNF1
) mice
. Immunology.
Crossref
Crossref
Monika Niewiem & Urszula Grzybowska-Chlebowczyk. (2022) Assessment of Selected Intestinal Permeability Markers in Children with Food Allergy Depending on the Type and Severity of Clinical Symptoms. Nutrients 14:20, pages 4385.
Crossref
Crossref
Monika Niewiem & Urszula Grzybowska-Chlebowczyk. (2022) Intestinal Barrier Permeability in Allergic Diseases. Nutrients 14:9, pages 1893.
Crossref
Crossref
Matthieu Rouland, Lucie Beaudoin, Ophélie Rouxel, Léo Bertrand, Lucie Cagninacci, Azadeh Saffarian, Thierry Pedron, Dalale Gueddouri, Sandra Guilmeau, Anne-Françoise Burnol, Latif Rachdi, Asmaa Tazi, Juliette Mouriès, Maria Rescigno, Nathalie Vergnolle, Philippe Sansonetti, Ute Christine Rogner & Agnès Lehuen. (2022) Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia. Gut 71:2, pages 296-308.
Crossref
Crossref
Mia Øgaard Mønsted, Nora Dakini Falck, Kristina Pedersen, Karsten Buschard, Laurits Juulskov Holm & Martin Haupt-Jorgensen. (2021) Intestinal permeability in type 1 diabetes: An updated comprehensive overview. Journal of Autoimmunity 122, pages 102674.
Crossref
Crossref
Wangxin Liu, Xianliang Luo, Jun Tang, Qiufen Mo, Hao Zhong, Hui Zhang & Fengqin Feng. (2020) A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. European Journal of Nutrition 60:5, pages 2317-2330.
Crossref
Crossref
Sonia R. Isaacs, Dylan B. Foskett, Anna J. Maxwell, Emily J. Ward, Clare L. Faulkner, Jessica Y. X. Luo, William D. Rawlinson, Maria E. Craig & Ki Wook Kim. (2021) Viruses and Type 1 Diabetes: From Enteroviruses to the Virome. Microorganisms 9:7, pages 1519.
Crossref
Crossref
Heli Siljander, Eeva Jason, Terhi Ruohtula, Jenni Selvenius, Katariina Koivusaari, Marja Salonen, Suvi Ahonen, Jarno Honkanen, Jorma Ilonen, Outi Vaarala, Suvi M. Virtanen, Marja-Leena Lähdeaho & Mikael Knip. (2021) Effect of Early Feeding on Intestinal Permeability and Inflammation Markers in Infants with Genetic Susceptibility to Type 1 Diabetes: A Randomized Clinical Trial. The Journal of Pediatrics.
Crossref
Crossref
Emma E. Hamilton-Williams, Graciela L. Lorca, Jill M. Norris & Jessica L. Dunne. (2021) A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis. Frontiers in Nutrition 8.
Crossref
Crossref
Lauren K. Wood Heickman, Mark D. DeBoer & Alessio Fasano. (2020) Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes/Metabolism Research and Reviews 36:5.
Crossref
Crossref
Bradley LeechBradley McEwenEric Owusu Sekyere. (2020) Diet, Digestive Health, and Autoimmunity: The Foundations to an Autoimmune Disease Food Pyramid—Part 1. Alternative and Complementary Therapies 26:3, pages 112-118.
Crossref
Crossref
He Zhou, Lin Sun, Siwen Zhang, Xue Zhao, Xiaokun Gang & Guixia Wang. (2020) Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms. Frontiers in Endocrinology 11.
Crossref
Crossref
Jarno Honkanen, Arja Vuorela, Daniel Muthas, Laura Orivuori, Kristiina Luopajärvi, Mysore Vishakante Gowda Tejesvi, Anton Lavrinienko, Anna Maria Pirttilä, Christopher L. Fogarty, Taina Härkönen, Jorma Ilonen, Terhi Ruohtula, Mikael Knip, Janne J. Koskimäki & Outi Vaarala. (2020) Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity. Frontiers in Immunology 11.
Crossref
Crossref
Yanfen Liu & Xueyong Lou. (2020) Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics 75, pages e1277.
Crossref
Crossref
M. Hanief Sofi, Benjamin M. Johnson, Radhika R. Gudi, Amy Jolly, Marie-Claude Gaudreau & Chenthamarakshan Vasu. (2019)
Polysaccharide A–Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal
Bacteroides fragilis
in Type 1 Diabetes
. Diabetes 68:10, pages 1975-1989.
Crossref
Crossref
Josephine Ho, Alissa C Nicolucci, Heidi Virtanen, Alana Schick, Jon Meddings, Raylene A Reimer & Carol Huang. (2019) Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism 104:10, pages 4427-4440.
Crossref
Crossref
Valter R.M. Lombardi, Iván Carrera, Lola Corzo & Ramón Cacabelos. (2019) Role of bioactive lipofishins in prevention of inflammation and colon cancer. Seminars in Cancer Biology 56, pages 175-184.
Crossref
Crossref
Jessica E. Harbison, Alexandra J. Roth‐Schulze, Lynne C. Giles, Cuong D. Tran, Katrina M. Ngui, Megan A. Penno, Rebecca L. Thomson, John M. Wentworth, Peter G. Colman, Maria E. Craig, Grant Morahan, Anthony T. Papenfuss, Simon C. Barry, Leonard C. Harrison & Jennifer J. Couper. (2019) Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatric Diabetes.
Crossref
Crossref
Bradley Leech, Janet Schloss & Amie Steel. (2019) Association between increased intestinal permeability and disease: A systematic review. Advances in Integrative Medicine 6:1, pages 23-34.
Crossref
Crossref
Alexandra PaunChristopher Yau, Shahab MeshkibafMichelle C. Daigneault, Leili MarandiSteven Mortin-Toth, Amit Bar-OrEmma Allen-Vercoe, Philippe PoussierJayne S. Danska. (2019) Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children. Science Immunology 4:32.
Crossref
Crossref
Lisa Rizzetto, Francesca Fava, Kieran M. Tuohy & Carlo Selmi. (2018) Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. Journal of Autoimmunity 92, pages 12-34.
Crossref
Crossref
Bradley Leech, Janet Schloss & Amie Steel. (2018) Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey. Complementary Therapies in Clinical Practice 31, pages 200-209.
Crossref
Crossref
Angela M. Henschel, Susanne M. Cabrera, Mary L. Kaldunski, Shuang Jia, Rhonda Geoffrey, Mark F. Roethle, Vy Lam, Yi-Guang Chen, Xujing Wang, Nita H. Salzman & Martin J. Hessner. (2018) Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune diabetes susceptibility. PLOS ONE 13:1, pages e0190351.
Crossref
Crossref
Cambrian Y. Liu, D. Brent Polk & Mark R. Frey. 2018. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
683
708
.
Megan Ciara Smyth. (2017) Intestinal permeability and autoimmune diseases. Bioscience Horizons: The International Journal of Student Research 10.
Crossref
Crossref
Ling Xiao, Belinda van’t Land, Wouter R. P. H. van de Worp, Bernd Stahl, Gert Folkerts & Johan Garssen. (2017) Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes. Frontiers in Immunology 8.
Crossref
Crossref
J S J Chia, J L McRae, S Kukuljan, K Woodford, R B Elliott, B Swinburn & K M Dwyer. (2017) A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes. Nutrition & Diabetes 7:5, pages e274-e274.
Crossref
Crossref
Silvia Pellegrini, Valeria Sordi, Andrea Mario Bolla, Diego Saita, Roberto Ferrarese, Filippo Canducci, Massimo Clementi, Francesca Invernizzi, Alberto Mariani, Riccardo Bonfanti, Graziano Barera, Pier Alberto Testoni, Claudio Doglioni, Emanuele Bosi & Lorenzo Piemonti. (2017) Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota. The Journal of Clinical Endocrinology & Metabolism 102:5, pages 1468-1477.
Crossref
Crossref
Naiomy Deliz Rios-Arce, Fraser L. Collins, Jonathan D. Schepper, Michael D. Steury, Sandi Raehtz, Heather Mallin, Danny T. Schoenherr, Narayanan Parameswaran & Laura R. McCabe. 2017. Understanding the Gut-Bone Signaling Axis. Understanding the Gut-Bone Signaling Axis
151
183
.
David Endesfelder, Marion Engel & Wolfgang zu Castell. (2016) Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions?. Current Diabetes Reports 16:7.
Crossref
Crossref
Xiaoping Yang, Duobing Zou, Songtao Tang, Tingting Fan, Huan Su, Ruolei Hu, Qing Zhou, Shuyu Gui, Li Zuo & Yuan Wang. (2016) Ameliorative effect of melatonin against increased intestinal permeability in diabetic rats: possible involvement of MLCK-dependent MLC phosphorylation. Molecular and Cellular Biochemistry 416:1-2, pages 23-32.
Crossref
Crossref
Susanne M. Cabrera, Angela M. Henschel & Martin J. Hessner. (2016) Innate inflammation in type 1 diabetes. Translational Research 167:1, pages 214-227.
Crossref
Crossref
Julie C. Antvorskov, Karsten Buschard & Knud Josefsen. 2016. Molecular Nutrition and Diabetes. Molecular Nutrition and Diabetes
51
62
.
Pilar Calo-Mata, Jose Manuel Ageitos, Karola Böhme & Jorge Barros-Velázquez. 2016. New Weapons to Control Bacterial Growth. New Weapons to Control Bacterial Growth
281
314
.
Ivana R. Sequeira, Roger G. Lentle, Marlena C. Kruger & Roger D. Hurst. (2015) Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial. PLOS ONE 10:12, pages e0143690.
Crossref
Crossref
Bidisha Paul, Stephen Barnes, Wendy Demark-Wahnefried, Casey Morrow, Carolina Salvador, Christine Skibola & Trygve O. Tollefsbol. (2015) Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clinical Epigenetics 7:1.
Crossref
Crossref
Xia Li & Mark A Atkinson. (2015) The role for gut permeability in the pathogenesis of type 1 diabetes - a solid or leaky concept?. Pediatric Diabetes 16:7, pages 485-492.
Crossref
Crossref
Kostas Kakleas, Alexandra Soldatou, Feneli Karachaliou & Kyriaki Karavanaki. (2015) Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmunity Reviews 14:9, pages 781-797.
Crossref
Crossref
Elke Gülden, F. Susan Wong & Li Wen. (2015) The gut microbiota and Type 1 Diabetes. Clinical Immunology 159:2, pages 143-153.
Crossref
Crossref
Austin G. Davis-Richardson & Eric W. Triplett. (2015) A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 58:7, pages 1386-1393.
Crossref
Crossref
Elaine Patterson, Tatiana M. Marques, Orla O’Sullivan, Patrick Fitzgerald, Gerald F. Fitzgerald, Paul D. Cotter, Timothy G. Dinan, John F. Cryan, Catherine Stanton & R. Paul Ross. (2015) Streptozotocin-induced type-1-diabetes disease onset in Sprague–Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology 161:1, pages 182-193.
Crossref
Crossref
Yi-Guang Chen, Susanne M. Cabrera, Shuang Jia, Mary L. Kaldunski, Joanna Kramer, Sami Cheong, Rhonda Geoffrey, Mark F. Roethle, Jeffrey E. Woodliff, Carla J. Greenbaum, Xujing Wang & Martin J. Hessner. (2014) Molecular Signatures Differentiate Immune States in Type 1 Diabetic Families. Diabetes 63:11, pages 3960-3973.
Crossref
Crossref
Julie C. Antvorskov, Knud Josefsen, Kåre Engkilde, David P. Funda & Karsten Buschard. (2014) Dietary gluten and the development of type 1 diabetes. Diabetologia 57:9, pages 1770-1780.
Crossref
Crossref
Henna Kallionpää, Laura L. Elo, Essi Laajala, Juha Mykkänen, Isis Ricaño-Ponce, Matti Vaarma, Teemu D. Laajala, Heikki Hyöty, Jorma Ilonen, Riitta Veijola, Tuula Simell, Cisca Wijmenga, Mikael Knip, Harri Lähdesmäki, Olli Simell & Riitta Lahesmaa. (2014) Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility. Diabetes 63:7, pages 2402-2414.
Crossref
Crossref
Mora Murri, Isabel Leiva, Juan Miguel Gomez-Zumaquero, Francisco J Tinahones, Fernando Cardona, Federico Soriguer & María Isabel Queipo-Ortuño. (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Medicine 11:1.
Crossref
Crossref
Kendra Vehik, Nadim J. Ajami, David Hadley, Joseph F. Petrosino & Brant R. Burkhardt. (2013) The Changing Landscape of Type 1 Diabetes: Recent Developments and Future Frontiers. Current Diabetes Reports 13:5, pages 642-650.
Crossref
Crossref
William E. Barbeau. (2012) What is the key environmental trigger in type 1 diabetes — Is it viruses, or wheat gluten, or both?. Autoimmunity Reviews 12:2, pages 295-299.
Crossref
Crossref
M. A. Atkinson & A. Chervonsky. (2012) Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55:11, pages 2868-2877.
Crossref
Crossref
Alberto M. Davalli, Carla Perego & Franco B. Folli. (2012) The potential role of glutamate in the current diabetes epidemic. Acta Diabetologica 49:3, pages 167-183.
Crossref
Crossref
Outi Vaarala. (2012) Is the origin of type 1 diabetes in the gut?. Immunology & Cell Biology 90:3, pages 271-276.
Crossref
Crossref
Outi Vaarala. 2012. Gastroenterology and Nutrition: Neonatology Questions and Controversies. Gastroenterology and Nutrition: Neonatology Questions and Controversies
91
99
.
Brian P. Boerner & Nora E. Sarvetnick. (2011) Type 1 diabetes: role of intestinal microbiome in humans and mice. Annals of the New York Academy of Sciences 1243:1, pages 103-118.
Crossref
Crossref
S. de Kort, D. Keszthelyi & A. A. M. Masclee. (2011) Leaky gut and diabetes mellitus: what is the link?. Obesity Reviews 12:6, pages 449-458.
Crossref
Crossref
Kendra Vehik & Dana Dabelea. (2011) The changing epidemiology of type 1 diabetes: why is it going through the roof?. Diabetes/Metabolism Research and Reviews 27:1, pages 3-13.
Crossref
Crossref
J. T. J. Visser, K. Lammers, A. Hoogendijk, M. W. Boer, S. Brugman, S. Beijer-Liefers, A. Zandvoort, H. Harmsen, G. Welling, F. Stellaard, N. A. Bos, A. Fasano & J. Rozing. (2010) Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 53:12, pages 2621-2628.
Crossref
Crossref
Nan Li, Marguerite Hatch, Clive H Wasserfall, Martha Douglas-Escobar, Mark A Atkinson, Desmond A Schatz & Josef Neu. (2010) Butyrate and Type 1 Diabetes Mellitus: Can We Fix the Intestinal Leak?. Journal of Pediatric Gastroenterology & Nutrition 51:4, pages 414-417.
Crossref
Crossref
Wahiba Sakly, Amani Mankaï, Nabil Sakly, Yosra Thabet, Achouak Achour, Leila Ghedira-Besbes, Moncef Jeddi & Ibtissem Ghedira. (2010) Anti-Saccharomyces cerevisiae Antibodies are Frequent in Type 1 Diabetes. Endocrine Pathology 21:2, pages 108-114.
Crossref
Crossref
A. S. Lee, D. L. Gibson, Y. Zhang, H. P. Sham, B. A. Vallance & J. P. Dutz. (2009) Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53:4, pages 741-748.
Crossref
Crossref
M Simpson, M Mojibian, K Barriga, FW Scott, A Fasano, M Rewers & JM Norris. (2009) An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatric Diabetes 10:8, pages 563-572.
Crossref
Crossref
Richard L Mones. (2009) Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten-Free Diet. Journal of Pediatric Gastroenterology & Nutrition 48:5, pages 645-646.
Crossref
Crossref
Outi Vaarala. (2008) Leaking gut in type 1 diabetes. Current Opinion in Gastroenterology 24:6, pages 701-706.
Crossref
Crossref
Outi Vaarala, Mark A. Atkinson & Josef Neu. (2008) The “Perfect Storm” for Type 1 Diabetes. Diabetes 57:10, pages 2555-2562.
Crossref
Crossref
Leonard C Harrison. (2008) Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunology & Cell Biology 86:2, pages 139-145.
Crossref
Crossref
Jose Luis Santiago, Alfonso Martínez, Concepción Núñez, Hermenegildo de la Calle, Miguel Fernández-Arquero, Emilio G. de la Concha & E. Urcelay. (2008) Association of MYO9B haplotype with type 1 diabetes. Human Immunology 69:2, pages 112-115.
Crossref
Crossref
A. Franzese, F. Lombardi, G. Valerio & M.I. Spagnuolo. (2007) Update on Coeliac Disease and Type 1 Diabetes Mellitus in Childhood. Journal of Pediatric Endocrinology and Metabolism 20:12.
Crossref
Crossref
William E. Barbeau, Josep Bassaganya-Riera & Raquel Hontecillas. (2007) Putting the pieces of the puzzle together – a series of hypotheses on the etiology and pathogenesis of type 1 diabetes. Medical Hypotheses 68:3, pages 607-619.
Crossref
Crossref
J Neu. (2006) NICHD: AAP workshop on neonatology research and training areas of research in neonatal gastroenterology. Journal of Perinatology 26:S2, pages S19-S22.
Crossref
Crossref
Anna Sapone, Laura de Magistris, Michelle Pietzak, Maria G. Clemente, Amit Tripathi, Francesco Cucca, Rosanna Lampis, Deborah Kryszak, Maria Cartenì, Maddalena Generoso, Dario Iafusco, Francesco Prisco, Francesca Laghi, Gabriele Riegler, Romano Carratu, Debra Counts & Alessio Fasano. (2006) Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives. Diabetes 55:5, pages 1443-1449.
Crossref
Crossref
Z Liu, N Li & J Neu. (2007) Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatrica 94:4, pages 386-393.
Crossref
Crossref
Tammara Watts, Irene Berti, Anna Sapone, Tania Gerarduzzi, Tarcisio Not, Ronald Zielke & Alessio Fasano. (2005) Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proceedings of the National Academy of Sciences 102:8, pages 2916-2921.
Crossref
Crossref
M Secondulfo, D Iafusco, R Carratù, L deMagistris, A Sapone, M Generoso, A Mezzogiorno, F.C Sasso, M Cartenı̀, R De Rosa, F Prisco & V Esposito. (2004) Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Digestive and Liver Disease 36:1, pages 35-45.
Crossref
Crossref
Mikael Knip. (2003) Cow's milk antibodies in patients with newly diagnosed type 1 diabetes: primary or secondary?. Pediatric Diabetes 4:4, pages 155-156.
Crossref
Crossref